Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.

XLRN

Acceleron Pharma (XLRN)

Acceleron Pharma Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:XLRN
FechaHoraFuenteTítuloSímboloCompañía
13/02/201906:00Business WireAcceleron to Present at Two Upcoming Healthcare Investor ConferencesNASDAQ:XLRNAcceleron Pharma Inc
11/02/201910:04Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:XLRNAcceleron Pharma Inc
29/01/201916:51Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:XLRNAcceleron Pharma Inc
22/01/201916:02Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:XLRNAcceleron Pharma Inc
17/01/201915:45Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:XLRNAcceleron Pharma Inc
17/01/201915:44Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(2) (424b2)NASDAQ:XLRNAcceleron Pharma Inc
16/01/201906:00Business WireAcceleron Announces Pricing of Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
14/01/201916:31Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:XLRNAcceleron Pharma Inc
14/01/201915:04Business WireAcceleron Announces Proposed Public Offering of Common StockNASDAQ:XLRNAcceleron Pharma Inc
10/01/201906:00Business WireAcceleron Announces Publication of Luspatercept Phase 2 Beta-Thalassemia Study Results in BloodNASDAQ:XLRNAcceleron Pharma Inc
02/01/201906:00Business WireAcceleron to Webcast Presentation at the 37th Annual J.P. Morgan Healthcare ConferenceNASDAQ:XLRNAcceleron Pharma Inc
19/12/201809:24Business WireDie Celgene Corp. und Acceleron Pharma geben bei der ASH-Jahrestagung 2018 die Ergebnisse der Phase-III-Studie BELIEVE zu Lus...NASDAQ:XLRNAcceleron Pharma Inc
07/12/201801:00Business WireASH 2018: Celgene Corp. e Acceleron Pharma annunciano i risultati dello studio di fase 3 BELIEVE per la valutazione di luspat...NASDAQ:XLRNAcceleron Pharma Inc
05/12/201815:30Business WireAcceleron Announces Luspatercept Phase 3 MEDALIST & BELIEVE Presentations Selected for “Best of ASH” by the American Soci...NASDAQ:XLRNAcceleron Pharma Inc
01/12/201816:00Business WireCelgene Corp. & Acceleron Pharma Announce Results of the Phase 3 BELIEVE Trial Evaluating Luspatercept in Adult Patients with...NASDAQ:XLRNAcceleron Pharma Inc
28/11/201806:00Business WireAcceleron Receives FDA Fast Track Designation for ACE-083 in Charcot-Marie-Tooth DiseaseNASDAQ:XLRNAcceleron Pharma Inc
27/11/201806:00Business WireAcceleron to Host Conference Call & Webcast to Review MEDALIST & BELIEVE Phase 3 Trial Presentations of Luspatercept at the 6...NASDAQ:XLRNAcceleron Pharma Inc
26/11/201806:00Business WireAcceleron to Participate in Two Upcoming Healthcare Investor ConferencesNASDAQ:XLRNAcceleron Pharma Inc
07/11/201806:00Business WireAcceleron Announces Preclinical Presentations on Sotatercept in Pulmonary Arterial Hypertension at the 2018 American Heart As...NASDAQ:XLRNAcceleron Pharma Inc
01/11/201808:01Business WireAcceleron Announces that Phase 3 Results from the MEDALIST & BELIEVE Trials of Luspatercept will be Presented at the 60th Ame...NASDAQ:XLRNAcceleron Pharma Inc
30/10/201815:29Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:XLRNAcceleron Pharma Inc
30/10/201815:05Business WireAcceleron Reports Third Quarter 2018 Operating and Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
23/10/201806:00Business WireAcceleron to Webcast Third Quarter 2018 Operating and Financial Results on October 30, 2018NASDAQ:XLRNAcceleron Pharma Inc
16/10/201806:00Business WireAcceleron to Host Pulmonary Arterial Hypertension Research and Development Deep Dive Event on November 16, 2018 in New York C...NASDAQ:XLRNAcceleron Pharma Inc
27/09/201806:00Business WireAcceleron Announces Presentations on ACE-083 at the 23rd International Annual Congress of the World Muscle SocietyNASDAQ:XLRNAcceleron Pharma Inc
04/09/201813:43Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:XLRNAcceleron Pharma Inc
04/09/201806:00Business WireAcceleron to Participate in Three Upcoming Healthcare Investor ConferencesNASDAQ:XLRNAcceleron Pharma Inc
02/08/201815:05Business WireAcceleron Reports Second Quarter 2018 Operating and Financial ResultsNASDAQ:XLRNAcceleron Pharma Inc
26/07/201806:00Business WireAcceleron to Webcast Second Quarter 2018 Operating and Financial Results on August 2, 2018NASDAQ:XLRNAcceleron Pharma Inc
23/07/201806:00Business WireAcceleron Announces Preliminary Results from Part 1 of the ACE-083 Phase 2 Trial in Patients with Charcot-Marie-Tooth Disease...NASDAQ:XLRNAcceleron Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:XLRN